ELAPRASE (Shire US Manufacturing Inc.)
Welcome to the PulseAid listing for the ELAPRASE drug offered from Shire US Manufacturing Inc.. This alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Shire US Manufacturing Inc. |
NON-PROPRIETARY NAME: | idursulfase |
SUBSTANCE NAME: | IDURSULFASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2006-07-24 |
END MARKETING DATE: | 0000-00-00 |
ELAPRASE HUMAN PRESCRIPTION DRUG Details:
Item Description | ELAPRASE from Shire US Manufacturing Inc. |
LABELER NAME: | Shire US Manufacturing Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(mg/3mL) |
START MARKETING DATE: | 2006-07-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54092-700_2db83830-65c2-6b1e-e054-00144ff8d46c |
PRODUCT NDC: | 54092-700 |
APPLICATION NUMBER: | BLA125151 |
Other IDURSULFASE Pharmaceutical Manufacturers / Labelers: